Neudle.com: dopamine receptor

Neurology Specific Literature Search

Differential
(Click to cross reference)

acquired immunodeficiency syndrome

activities of daily living

Addison's disease

advances in neurology

adverse drug reaction

airway obstruction

alcohol intolerance

alcohol, neurologic complications with

alpha methyltyrosine

alpha-synuclein

altered states of consciousness, driving with

anemia, iron deficiency

angiitis, isolated of CNS

angiography, cerebral

anti basal ganglia antibodies

anticholinergic drugs

anticholinergic drugs, side effects of

anticonvulsants

anticonvulsants, untoward effects of

anti-dopamine 2 receptor antibody

anxiolytic agents

aortic valve, lesion of

aphasia, rehabilitation

arrhythmia, cardiac

arterial dissection, aorta, cerebral symptoms with

ataxia, truncal

attention deficit disorder with hyperactivity

autoimmune basal ganglia encephalitis

autoimmune disease

automobile accidents

autonomic dysfunction

basal ganglia, lesion of

basal ganglia, lesion, bilateral

behavioral disorder

biologic markers

bitemporal visual field defect

bladder dysfunction

blinking, reduced

botulinum toxin

brain transplantation

bromocriptine, slow release

Brueghel's syndrome

carcinoma of breast

carpal tunnel syndrome

CAT scan, abnormal

CAT scan, chest

CAT scan, emission

CAT scan, emission, abnormal

catechol-o-methyltransferase inhibitor

central nervous system, infection of

cerebellar pontine angle

cerebellar pontine angle tumor

cerebral dominance

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, leak

cerebrovascular accident

cerebrovascular accident, women

chest x-ray, abnormal

Chiari Frommel syndrome

chiasmal syndromes

chorea, treatment of

choreoathetosis

chromophobe adenoma

chromophobe adenoma, treatment of

cisternogram, radionuclide

cluster headache

congestive heart failure

conjunctival injection

controversies in neurology

conversion reaction

coronary artery disease

cost effectiveness

cranial nerve palsies

creatine phosphokinase(CPK)elevated

Cushing's syndrome

dantrolene sodium

degenerative diseases of CNS

dementia, rapidly progressive

dementia, screening for

dexamethasone suppression test

diabetes mellitus

differential diagnosis

dilantin, toxicity

diphenhydramine

disability rating scale, neurological

disability, neurological

diurnal variation

dopamine agonist

dopamine agonist withdrawal syndrome

dopamine antagonist

dopamine antagonist, peripheral

dopamine receptor

dopamine receptor, D2

doppler, transcranial

downward gaze, paralysis of

drug induced neurologic disorders

drug withdrawal

dyskinesia, buccal lingual facial

dyskinesia, drug induced

dystonia, drug induced

dystonia, treatment of

dystonic reaction, acute

echocardiogram, transthoracic

emergencies, neurologic

empty sella syndrome

encephalitis, autoimmune

encephalitis, viral

encephalopathy, Hashimoto's

encephalopathy, metabolic

encephalopathy, progressive

enzyme inhibition

eosinophilic adenoma

epidemiology of neurology

erectile dysfunction

erythromelalgia

eye movement, disorders of

fine motor function, impaired

follicle stimulating hormone

gait, festinating

gastrointestinal bleeding

gaze palsy, horizontal

gaze palsy, vertical

Gilles de la Tourette syndrome

growth hormone deficiency

hallucination, auditory

headache, drug induced

headache, emergency

headache, evaluation of

headache, prophylaxis

headache, treatment of

hepatic encephalopathy

hepatic encephalopathy, treatment of

hepatolenticular degeneration(Wilson's disease)

heralding manifestation

Huntington's chorea

hypometric saccades

hypopituitarism

hypothalamus, damage to

iatrogenic neurologic disorders

imbalance, postural

intellectual deficit

internuclear ophthalmoplegia

intracerebral hemorrhage

Jakob-Creutzfeldt disease

kinesia paradoxica

L-dopa, controlled release

L-dopa, drug interactions with and side effects of

level of consciousness, decreased

Lewy body disease, diffuse

libido, decreased

libido, increased

lumbar puncture, indications for

luteinizing hormone

marche a petits pas

medication withdrawal

mental status, abnormal

microsurgery, transsphenoidal

migraine, menses

migraine, pregnancy

migraine, prophylaxis

migraine, treatment of

mitral valve lesion

mitral valve regurgitation

monoamine oxidase inhibitors

movement disorder

movement disorder, drug induced

movement disorder, extrapyramidal

movement disorder, extrapyramidal-treatment of

movement disorder, post hemiplegic

movement disorder, treatment of

MRI, contrast enhanced

MRI, diffusion weighted

MRI, disappearing lesion on

MRI, indications for

multiple sclerosis

multiple system atrophy

muscle relaxant

narcotic analgesics

nausea and vomiting

Nelson's syndrome

neoplasm, metastatic to CNS

neoplasm, metastatic to CNS-treatment of

neoplasm, pituitary

neoplasm, pituitary, incidental

neoplasm, pituitary, treatment of

neoplasm, primary of CNS-metastasizing to subarachnoid space

neoplasm, primary of CNS-treatment of

neuroendocrinology

neuroleptic malignant syndrome

neuroleptic, atypical

neurologic complications of, surgery

neurologic disease

neurologic disease, diagnoses of

neurologic signs

neurologic symptoms

neurologic testing

neuronal degeneration

neuropathology, brain

neuroprotective agents

neurotransmitter

NMDA antagonists

nonsteroidal anti-inflammatory drug

obsessive-compulsive disorder

oculogyric crisis

optic chiasm, herniation

oral contraceptives

oral contraceptives, neurologic complications with

orthostatic hypotension

Othello syndrome

Parkinson disease

Parkinson disease, dementia with

Parkinson disease, diagnosis

Parkinson disease, differential diagnosis of

Parkinson disease, driving with

Parkinson disease, drug induced

Parkinson disease, dystonia with

Parkinson disease, early symptoms

Parkinson disease, etiology of

Parkinson disease, exacerbation

Parkinson disease, fluctuations in

Parkinson disease, freezing phenomena in

Parkinson disease, nonmotor problems of

Parkinson disease, on-off phenomena in

Parkinson disease, pathogenesis of

Parkinson disease, presymptomatic detection

Parkinson disease, prognosis of

Parkinson disease, progression

Parkinson disease, sensory symptoms in

Parkinson disease, surgical treatment of

Parkinson disease, transient

Parkinson disease, treatment of

Parkinsonism syndrome

pathologic gambling

patient information and support

PHNO, enteral infusion, continuous

PHNO, intravenous

pituitary, adenoma

pituitary, adenoma, giant

pituitary, enlargement

pituitary, hormones of

pituitary, lesion of

pituitary, microadenoma

pleocytosis of cerebrospinal fluid

pleural effusion

pleural fibrosis

polyps, gastrointestinal tract

postpartum cerebral angiopathy

practice guidelines

pramipexole, extended release

pregnancy, neurologic complications in

prevention of neurologic disorders

progressive supranuclear palsy

prolactin, elevated

proton beam therapy

psychiatric disorder

psychiatric problems in neurologic disorders

psychotic behavior

pyruvate-kinase deficiency anemia

quality of care

radiation necrosis

radiation therapy, CNS treatment and complications with

radiation therapy, stereotactic

radioimmunoassay

radiotracer imaging

rapidly progressing neurologic illness

remote effect of cancer on the nervous system

reserpine and reserpine like drugs

respiratory failure

restless arms syndrome

restless genital syndrome

restless leg syndrome

retroperitoneal fibrosis

rhinorrhea, CSF

risk-benefit assessment

ropinirole, prolonged release

sarcoidosis, CNS

sella turcica, enlargement of

sensorineural hearing loss

serotonin agonist

serum tumor markers

single photon emission computed tomography

skin, lesions in neurologic disorders

skull x-ray, abnormal

sleep pathology and physiology

Smell Identification Test

somatostatin analogue

stem cell transplantation

steroid therapy, CNS treatment and complications with

stimulation, deep brain

striatal encephalitis

striatonigral degeneration

striatum, lesion of

striatum, lesion of, bilateral

subclavian steal syndrome, causes of

synucleinopathy

tardive akathisia

tardive dyskinesia

tardive dyskinesia, treatment of

tardive dystonia

tardive pain syndrome

tension headache

testicular atrophy

testosterone, serum

testosterone, serum, low

tic, chronic multiple

tic, classification of

tongue, enlarged

toxic encephalopathy

transdermal medication

treatment of neurologic disorder

tremor, resting

tremor, thalamic stimulation for suppression of

tricuspid valve, lesion of

trifluoperazine

Unified Parkinson Rating Scale

urinary incontinence

vasospasm, cerebral

viral infection, CNS

visual acuity, decreased

visual field defect

West Nile fever

Showing articles 100 to 150 of 945 << Previous Next >>

Multicenter, Placebo-Controlled Trial of Cabergoline Taken Once Daily in the Treatment of Parkinson's Disease
Neurol 46:1062-1065, Hutton,J.T.,et al, 1996

Double-Blind Comparison of Cabergoline & Bromocriptine in Parkinson's Disease Pts with Motor Fluctuations
Neurol 47:785-788, Inzelberg,R.,et al, 1996

Bromocriptine and Postpartum Cerebral Angiopathy:A Causal Relationship
Neurol 46:1754-1756, Comabella,M.,et al, 1996

Increased Incidence of Levodopa Therapy Following Metoclopramide Use
JAMA 274:1780-1782, Avorn,J.,et al, 1995

The Effect of Comb Oral Lysine Acetylsalicylate & Metoclopramide Compared w/Oral Sumatriptan for Migraine
Lancet 346:923-926, Tfelt-Hansen,P.,et al, 1995

Complementary Positron Emission Tomographic Studies of the Striatal Dopaminergic System in Parkinson's Disease
Arch Neurol 52:1183-1190, Antonini,A.,et al, 1995

Drug Treatment of Parkinson's Disease
BMJ 310:575-579, Quinn,N., 1995

Retroperitoneal Fibrosis in a Patient with Parkinson's Disease Treated with Pergolide
Clin NeuroPharmacol 18:277-279, Jimenez-Jimenez,F.J.,et al, 1995

Postpartum Cerebral Angiopathy Possibly Due to Bromocriptine Therapy
Stroke 26:128-130, Janssens,E.,et al, 1995

A Multicenter Double-Blind Placebo-Controlled Trial of Pergolide as an Adjunct to Sinemet in Parkinson's Disease
Movement Disorders, 9:40-471994., Olanow,C.W.,et al, 1994

Parkinson's Disease
JNNP 57:672-681, Marsden,C.D., 1994

Reverse Shapiro's Syndrome:Hirayama
K. , et al, Arch Neurol 51:494-49694., , 1994

Diagnosis and Management of Pituitary Tumours
BMJ 308:1087-1091, Levy,A.&Lightman,S.L., 1994

Treatment with D-penicillamine Improves Dopamine D2-Receptor Binding and T2-Signal Intensity in de novo Wilson's Disease
Neurol 44:1079-1082, Schwarz,J.,et al, 1994

Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
NEJM 330:613-622, Lipton,S.A.&Rosenberg,P.A., 1994

Fluctuating Parkinson's Disease:Treatment with the Long-Acting Dopamine Agonist Cabergoline
Arch Neurol 51:1236-1241, Ahlskog,J.E.,et al, 1994

Oral and Genital Tardive Pain Syndromes
Neurol 44:2115-2119, Ford,B.,et al, 1994

Drug Therapy of Migraine
NEJM 329:1476-1483, Welch,K.M.A., 1993

Comparisons of Therapeutic Effects of Levodopa
Levodopa & Selegiline, & Bromocriptine in Pts with Early, Mild Parkinson's, Parkinson's Res Grp in U, , BMJ 372,1993., 1993

Defecatory Function in Parkinson's Disease:Response to Apomorphine
Ann Neurol 33:490-493, Edwards,L.L.,et al, 1993

Multiple System Atrophy & Prog Supranuc Palsy, Dimin Striatal D2 Dopamine Receptor Act by SPECT
Arch Neurol 50:513-516, vanRoyen,E.,et al, 1993

Treatment of Parkinson's Disease
NEJM 329:1021-1027, Calne,D.B., 1993

Prolactin-Secreting Macroadenomas in Adolescents, Response to Bromocriptine Therapy
Am J Dis Child 147:1057-1061, Tyson,D.,et al, 1993

Acromegaly:Treatment After 100 Years
BMJ 307:1505-1506, Wass,J.A.H., 1993

Cabergoline in Parkinson's Disease:Long-Term Follow-up
Neurol 43:2587-2590, Lera,G.,et al, 1993

Multictr Study of Cabergoline, A Long-Acting Dopamine Receptor Agonist, in PD Fluct Resp to Levodopa/Carbidopa
Neurol 43:1981-1984, Lieberman,A.,et al, 1993

Schizophrenia as a Brain Disease, The Dopamine Receptor Story
Arch Neurol 50:1093-1095, 10971993., Seeman,P., 1993

The Prevalence of Metoclopramide-Induced Tardive Dyskinesia and Acute Extrapyramidal Movement Disorders
Arch Int Med 153:1469-1475, Ganzini,L.,et al, 1993

Dopamine Agonist Treatment of Fluctuating Parkinsonisn
Arch Neurol 49:560-568, Ahlskog,J.E.,et al, 1992

Acute Respiratory Failure from Dopamine Agonist Withdrawal
Neurol 42:1843-1844, Riley,D.E.,et al, 1992

Tardive Dyskinesia Associated with Use of Metoclopramide in a Child
J Pediatr 121:983-985, Putnam,P.E.,et al, 1992

Striatal D2 Receptor Status in Patients with Parkinson's Disease, Striatonigral Degeneration, and PSP, (PET)
Ann Neurol 31:184-192, Brooks,D.J.,et al, 1992

123I-iodobenzamide-SPECT Predicts Dopaminergic Responsiveness in patients with De Dovo Parkinsonism
Neurol 42:556-561, Schwarz,J.,et al, 1992

An Open-Label Trial of Bromocriptine in Nonfluent Aphasia
Neurol 42:1637-1638, Sabe,L.,et al, 1992

Emergency Treatment of Headache
Neurol 42 (Suppl 2) :43-44992., Rapoport,A.M.&Silberstein,S.D., 1992

Drug-Induced Movement Disorders:An Overview
In Movement Dis in Neurol & Neuropsych, Blackwell Sci Publ, Boston, 2:21., Miller,L.G.&Jankovic,J., 1992

Olanzapine in the Treatment of Dopaminomimetic Psychosis in Patients with Parkinson's Disease
Neurol 47:1085-1087, Wolters,W.Ch.,et al, 1992

Extrapyramidal side Effects of Antiemetics Presenting as Psychiatric Illness
Gen Hosp Psychiatry 14:192-195, Rodgers,C., 1992

A Multi-Center, Double-Blind Study on Slow-Release Bromocriptine in the Treatment of Parkinson's Disease
Neurol 41:1598-1602, Mannen,T.,et al, 1991

Pleuropulmonary Disease Associated with Dopamine Agonist Therapy
Ann Neurol 30:613-616, Bhatt,M.H.,et al, 1991

The Apomorphine Test in Parkinsonian Syndromes
JNNP 54:870-872, D'Costa,D.F.,et al, 1991

Diagnosis and Management of Hormone-Secreting Pituitary Adenomas
NEJM 324:822-831, Klibanski,A.&Zervas,N.T., 1991

Treatment of Prolactin-Secreting Pituitary Macroadenomas with the Long-Acting Non-Ergot Dopamine Agonist CV 205-502
Ann Int Med 112:668-673, Vance,M.L.,et al, 1990

Acromegaly
NEJM 322:966-977, Melmed,S., 1990

Bromocriptine-Induced Hypothermia
Neurol 40:383, Pfeiffer,R.F., 1990

Subcutaneous Apomorphine in the Treatment of Parkinson's Disease
JNNP 53:96-101, Frankel,J.P.,et al, 1990

Nasogastric and Intravenous Infusions of (+) -4-propyl-9-hydroxynaphthoxazine (PHNO) in Parkinson's Disease
JNNP 53:102-105, 1990, Coleman,R.J.,et al, 1990

Oculogyric Crisis after Metoclopramide Therapy
Optometry and Vision Science 66:179-180, Edward,M.,et al, 1989

Bromocriptine in Parkinson's Disease:A Double-Blind Study Comparing"Low-Slow"and"High-Fast"in de Novo Patients
UK Bromocriptine Res Group, JNNP 52:77-821989., , 1989

Lisuride, A Dopamine Agonist in the Treatment of Early Parkinson's Disease
Neurol 39:336-339, Rinne,U.K., 1989

Showing articles 100 to 150 of 945 << Previous Next >>